 | • レポートコード：MRC23Q36131 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（2-3日） • 産業分類：産業機械 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の自家調整検査（LDT）市場について調査・分析し、世界の自家調整検査（LDT）市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（臨床生化学、血液学、免疫学、分子診断学、その他）、用途別セグメント分析（病院 研究所、臨床研究機関、学術機関、専門診断センター、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Quest Diagnostics、Thermo Fisher、Waters Corporation、Roche、Illumina、Qiagen、Eurofins、Guardant Health、Adaptive Biotechnologies、Biodesix、Berry Oncology、Genetron Healthなどが含まれています。世界の自家調整検査（LDT）市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、自家調整検査（LDT）市場規模を推定する際に考慮しました。本レポートは、自家調整検査（LDT）の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、自家調整検査（LDT）に関するビジネス上の意思決定に役立てることを目的としています。 ・自家調整検査（LDT）市場の概要 - 自家調整検査（LDT）のタイプ別セグメント - 世界の自家調整検査（LDT）市場規模：タイプ別分析（臨床生化学、血液学、免疫学、分子診断学、その他） - 自家調整検査（LDT）の用途別セグメント - 世界の自家調整検査（LDT）市場規模：用途別分析（病院 研究所、臨床研究機関、学術機関、専門診断センター、その他） - 世界の自家調整検査（LDT）市場規模予測（2018年-2029年） ・自家調整検査（LDT）市場の成長トレンド - 自家調整検査（LDT）の地域別市場規模（2018年-2029年） - 自家調整検査（LDT）市場ダイナミクス - 自家調整検査（LDT）の業界動向 - 自家調整検査（LDT）市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：臨床生化学、血液学、免疫学、分子診断学、その他 - 世界の自家調整検査（LDT）のタイプ別市場規模（2018年-2023年） - 世界の自家調整検査（LDT）のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院 研究所、臨床研究機関、学術機関、専門診断センター、その他 - 世界の自家調整検査（LDT）の用途別市場規模（2018年-2023年） - 世界の自家調整検査（LDT）の用途別市場規模（2024年-2029年） ・自家調整検査（LDT）の地域別市場規模 - 北米の自家調整検査（LDT）市場規模（2018年-2029年） - アメリカの自家調整検査（LDT）市場規模（2018年-2029年） - ヨーロッパの自家調整検査（LDT）市場規模（2018年-2029年） - アジア太平洋の自家調整検査（LDT）市場規模（2018年-2029年） - 中国の自家調整検査（LDT）市場規模（2018年-2029年） - 日本の自家調整検査（LDT）市場規模（2018年-2029年） - 韓国の自家調整検査（LDT）市場規模（2018年-2029年） - インドの自家調整検査（LDT）市場規模（2018年-2029年） - オーストラリアの自家調整検査（LDT）市場規模（2018年-2029年） - 中南米の自家調整検査（LDT）市場規模（2018年-2029年） - 中東・アフリカの自家調整検査（LDT）市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Quest Diagnostics、Thermo Fisher、Waters Corporation、Roche、Illumina、Qiagen、Eurofins、Guardant Health、Adaptive Biotechnologies、Biodesix、Berry Oncology、Genetron Health ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Laboratory Developed Tests (LDT) market was valued at US$ 4934 million in 2022 and is anticipated to reach US$ 8403.2 million by 2029, witnessing a CAGR of 9.3% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global top 5 players of Laboratory Developed Tests (LDT) occupied for 53% of the market, including Quest Diagnostics, Thermo Fisher, Waters Corporation, Roche, Illumina. North America is the largest market of Laboratory Developed Tests (LDT), holding a share over 47%. Then Europe takes 25%. In terms of type, Molecular Diagnostics shares over 31% of the market, while Immunology shares 25%. In terms of application, Hospitals Laboratory shares the largest percent of nearly 56%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Laboratory Developed Tests (LDT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Laboratory Developed Tests (LDT).
The Laboratory Developed Tests (LDT) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Laboratory Developed Tests (LDT) market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Laboratory Developed Tests (LDT) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Quest Diagnostics
Thermo Fisher
Waters Corporation
Roche
Illumina
Qiagen
Eurofins
Guardant Health
Adaptive Biotechnologies
Biodesix
Berry Oncology
Genetron Health
Segment by Type
Clinical Biochemistry
Hematology
Immunology
Molecular Diagnostics
Other
Segment by Application
Hospitals Laboratory
Clinical Research Organizations
Academic Institutes
Specialty Diagnostic Centers
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Laboratory Developed Tests (LDT) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Laboratory Developed Tests (LDT) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Clinical Biochemistry
1.2.3 Hematology
1.2.4 Immunology
1.2.5 Molecular Diagnostics
1.2.6 Other
1.3 Market by Application
1.3.1 Global Laboratory Developed Tests (LDT) Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals Laboratory
1.3.3 Clinical Research Organizations
1.3.4 Academic Institutes
1.3.5 Specialty Diagnostic Centers
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Laboratory Developed Tests (LDT) Market Perspective (2018-2029)
2.2 Laboratory Developed Tests (LDT) Growth Trends by Region
2.2.1 Global Laboratory Developed Tests (LDT) Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Laboratory Developed Tests (LDT) Historic Market Size by Region (2018-2023)
2.2.3 Laboratory Developed Tests (LDT) Forecasted Market Size by Region (2024-2029)
2.3 Laboratory Developed Tests (LDT) Market Dynamics
2.3.1 Laboratory Developed Tests (LDT) Industry Trends
2.3.2 Laboratory Developed Tests (LDT) Market Drivers
2.3.3 Laboratory Developed Tests (LDT) Market Challenges
2.3.4 Laboratory Developed Tests (LDT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Laboratory Developed Tests (LDT) Players by Revenue
3.1.1 Global Top Laboratory Developed Tests (LDT) Players by Revenue (2018-2023)
3.1.2 Global Laboratory Developed Tests (LDT) Revenue Market Share by Players (2018-2023)
3.2 Global Laboratory Developed Tests (LDT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Laboratory Developed Tests (LDT) Revenue
3.4 Global Laboratory Developed Tests (LDT) Market Concentration Ratio
3.4.1 Global Laboratory Developed Tests (LDT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Laboratory Developed Tests (LDT) Revenue in 2022
3.5 Laboratory Developed Tests (LDT) Key Players Head office and Area Served
3.6 Key Players Laboratory Developed Tests (LDT) Product Solution and Service
3.7 Date of Enter into Laboratory Developed Tests (LDT) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Laboratory Developed Tests (LDT) Breakdown Data by Type
4.1 Global Laboratory Developed Tests (LDT) Historic Market Size by Type (2018-2023)
4.2 Global Laboratory Developed Tests (LDT) Forecasted Market Size by Type (2024-2029)
5 Laboratory Developed Tests (LDT) Breakdown Data by Application
5.1 Global Laboratory Developed Tests (LDT) Historic Market Size by Application (2018-2023)
5.2 Global Laboratory Developed Tests (LDT) Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Laboratory Developed Tests (LDT) Market Size (2018-2029)
6.2 North America Laboratory Developed Tests (LDT) Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Laboratory Developed Tests (LDT) Market Size by Country (2018-2023)
6.4 North America Laboratory Developed Tests (LDT) Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Laboratory Developed Tests (LDT) Market Size (2018-2029)
7.2 Europe Laboratory Developed Tests (LDT) Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Laboratory Developed Tests (LDT) Market Size by Country (2018-2023)
7.4 Europe Laboratory Developed Tests (LDT) Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Laboratory Developed Tests (LDT) Market Size (2018-2029)
8.2 Asia-Pacific Laboratory Developed Tests (LDT) Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Laboratory Developed Tests (LDT) Market Size by Region (2018-2023)
8.4 Asia-Pacific Laboratory Developed Tests (LDT) Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Laboratory Developed Tests (LDT) Market Size (2018-2029)
9.2 Latin America Laboratory Developed Tests (LDT) Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Laboratory Developed Tests (LDT) Market Size by Country (2018-2023)
9.4 Latin America Laboratory Developed Tests (LDT) Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Laboratory Developed Tests (LDT) Market Size (2018-2029)
10.2 Middle East & Africa Laboratory Developed Tests (LDT) Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Laboratory Developed Tests (LDT) Market Size by Country (2018-2023)
10.4 Middle East & Africa Laboratory Developed Tests (LDT) Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Quest Diagnostics
11.1.1 Quest Diagnostics Company Detail
11.1.2 Quest Diagnostics Business Overview
11.1.3 Quest Diagnostics Laboratory Developed Tests (LDT) Introduction
11.1.4 Quest Diagnostics Revenue in Laboratory Developed Tests (LDT) Business (2018-2023)
11.1.5 Quest Diagnostics Recent Development
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Detail
11.2.2 Thermo Fisher Business Overview
11.2.3 Thermo Fisher Laboratory Developed Tests (LDT) Introduction
11.2.4 Thermo Fisher Revenue in Laboratory Developed Tests (LDT) Business (2018-2023)
11.2.5 Thermo Fisher Recent Development
11.3 Waters Corporation
11.3.1 Waters Corporation Company Detail
11.3.2 Waters Corporation Business Overview
11.3.3 Waters Corporation Laboratory Developed Tests (LDT) Introduction
11.3.4 Waters Corporation Revenue in Laboratory Developed Tests (LDT) Business (2018-2023)
11.3.5 Waters Corporation Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Laboratory Developed Tests (LDT) Introduction
11.4.4 Roche Revenue in Laboratory Developed Tests (LDT) Business (2018-2023)
11.4.5 Roche Recent Development
11.5 Illumina
11.5.1 Illumina Company Detail
11.5.2 Illumina Business Overview
11.5.3 Illumina Laboratory Developed Tests (LDT) Introduction
11.5.4 Illumina Revenue in Laboratory Developed Tests (LDT) Business (2018-2023)
11.5.5 Illumina Recent Development
11.6 Qiagen
11.6.1 Qiagen Company Detail
11.6.2 Qiagen Business Overview
11.6.3 Qiagen Laboratory Developed Tests (LDT) Introduction
11.6.4 Qiagen Revenue in Laboratory Developed Tests (LDT) Business (2018-2023)
11.6.5 Qiagen Recent Development
11.7 Eurofins
11.7.1 Eurofins Company Detail
11.7.2 Eurofins Business Overview
11.7.3 Eurofins Laboratory Developed Tests (LDT) Introduction
11.7.4 Eurofins Revenue in Laboratory Developed Tests (LDT) Business (2018-2023)
11.7.5 Eurofins Recent Development
11.8 Guardant Health
11.8.1 Guardant Health Company Detail
11.8.2 Guardant Health Business Overview
11.8.3 Guardant Health Laboratory Developed Tests (LDT) Introduction
11.8.4 Guardant Health Revenue in Laboratory Developed Tests (LDT) Business (2018-2023)
11.8.5 Guardant Health Recent Development
11.9 Adaptive Biotechnologies
11.9.1 Adaptive Biotechnologies Company Detail
11.9.2 Adaptive Biotechnologies Business Overview
11.9.3 Adaptive Biotechnologies Laboratory Developed Tests (LDT) Introduction
11.9.4 Adaptive Biotechnologies Revenue in Laboratory Developed Tests (LDT) Business (2018-2023)
11.9.5 Adaptive Biotechnologies Recent Development
11.10 Biodesix
11.10.1 Biodesix Company Detail
11.10.2 Biodesix Business Overview
11.10.3 Biodesix Laboratory Developed Tests (LDT) Introduction
11.10.4 Biodesix Revenue in Laboratory Developed Tests (LDT) Business (2018-2023)
11.10.5 Biodesix Recent Development
11.11 Berry Oncology
11.11.1 Berry Oncology Company Detail
11.11.2 Berry Oncology Business Overview
11.11.3 Berry Oncology Laboratory Developed Tests (LDT) Introduction
11.11.4 Berry Oncology Revenue in Laboratory Developed Tests (LDT) Business (2018-2023)
11.11.5 Berry Oncology Recent Development
11.12 Genetron Health
11.12.1 Genetron Health Company Detail
11.12.2 Genetron Health Business Overview
11.12.3 Genetron Health Laboratory Developed Tests (LDT) Introduction
11.12.4 Genetron Health Revenue in Laboratory Developed Tests (LDT) Business (2018-2023)
11.12.5 Genetron Health Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details